Succinylcholine-induced potassium efflux was studied in two groups of healthy adult patients presenting for elective surgery. One group (Group I) of 12 patients received alfathesin induction followed by succinylcholine. The other group (Group 2) of 12 patients were pre-treated with fazadinium 0.075 mg-kg -~ about three minutes before administration of alfathesin and succinylcholine. Serial blood samples were taken pre-induction, post-induction and after succinylcholine for estimation of plasma potassium. The results show that pre-treatment with fazadinium 0.075 mg-kg -~ was effective in preventing succinylcholineinduced potassium efflux.
SUCCINYLCHOLINE is the muscle relaxant most commonly used to facilitate tracheal intubation. Its administration is often associated with fasciculations and an increase in plasma potassium which, though of little clinical significance in normal anaesthetized patients, has been reported to cause serious cardiac arrhythmias and cardiac arrest in patients with extensive soft tissue trauma, 1 bttrns, 2 tetanus, 3 paraplegia, 4 and neuromuscular disease. 5 Previous investigators 6,7,s have studied the influence of pretreatment with d-tubocurarine, gallamine and pancuronium on succinylcholine-induced potassium efflux. The results showed varying degrees of attenuation of the potassium efflux by the different nondepolarising muscle relaxants.
Fazadinium is a non-depolarising muscle relaxant recently introduced into clinical use. 9 The aim of this study was to determine the effect of pretreatment with a small dose of fazadinium (0.075 rag-kg -1) on the. plasma potassium changes produced by succinylcholine. The choice of this dose of fazadinium was based on an earlier study ~~ which showed that this was the smallest dose that consistently prevented succinylcholincinduced muscle fasciculations.
MATERIALS AND METHODS
Twenty-four adult Nigerian patients presenting for elective surgery were studied. Informed C.E. Famewo. M.B., B.S., Dip.Anaes. (Toronto). F.R.C.P(C), Consultant Anaesthetist, Department of Anaesthesia, College of Medicine, University of lbadan, lbadan, Nigeria. consent was obtained from the patients. All were free from neuromuscular, cardiovascular and electrolyte disorders (physical status ASA 1). Fourteen were male and 10 were females with ages between 20 and 60 years. They weighed between 65 and 72kg. All were premedicated with meperidine ling. kg -1 given by the intramuscular route about one hour before induction of anaesthesia ropine 0.6 mg was given intravenously at the time of induction. Twelve of the patients (Group 2) were pretreated with fazadinium 0.075 mg. kg -t about three minutes before induction while the other 12 (Group 1) did not receive fazadinium pretreatment and served as the control group. The two groups were comparable in age, sex and weight.
Anaesthesia was induced in both groups with alfathesin 0.075rag-kg -t followed by succiny[-choline bromide 40 rag. The maintenance of anaesthesia was with nitrous oxide and oxygen (2: I ratio) throughout the sampling period, while ventilation was manually controlled with a face mask until spontaneous respiration was reestablished. Surgical incision was not made until blood sampling was completed.
Venous blood samples were taken through an 18-gauge cannula inserted into a vein in the forearm other than the one used for injection of anaesthetic drugs. The cannula was large enough to allow free flow of blood without the application of tourniquet. The samples were collected into lithium heparin bottles at the following times: (i) before induction of anaesthesia (baseline); (ii) 2 minutes after alfathesin induction; (iii) 2 minutes 463 Canad. Anaesth. Soc. J., vol. 28, no. 5, September 1981 after succinylcholine; (iv) 5 minutes after succinylcholine; and (v) 10 minutes after succinylcholine.
The samples were immediately sent to the laboratory where they were centrifuged and the plasma separated. The plasma potassium levels were determined using a flame photometer (EEL 450). Previous duplicate analysis with the flame photometer showed good repeatability and accuracy with a variation of less than one percent.
Blood gases were analysed in four patients chosen at random (two from each group) to verify the adequacy of ventilation and oxygenation during the sampling period. The ABL blood gas machine was used for the analysis.
Statistical comparisions of the plasma potassium changes were made using student's t test. A probability of 0.5 per cent or less (p < 0.05) was considered significant.
RESULTS
The changes in plasma potassium following atfathesin induction and succinylcholine administration are shown in Table I . Alfathesin did not produce any significant change in plasma potassium in either group. However, there was a significant increase (P < 0.01) in plasma potassium in group I following the administration of succinylcholine which peaked between two minutes and five minutes after administration. In Group 2 (pretreated with fazadinium) there was no significant change in the plasma potassium following administration of succinylcholine. Muscle fasciculations were observed in all the patients that received succinylcholine without pretreatment with fazadinium, but were absent in those patients pretreated with fazadinium.
The patients who were pretreated with fazadinium complained of pain at the injection site during administration of the drug, while some expressed the feeling of drowsiness or dizziness. These symptons were usually transient and did not unduly bother the patients.
The results of the blood gas analysis done were within normal limits. DISCUSSION Succinylcholine-induced hyperkalaemia in patients with extensive soft tissue injury, burns and neuromuscular disorders is thought to be due to the release of unusually large amounts of potassium from skeletal muscles during muscle fasciculation. To facilitate tracheal intubation in these categories of patients, the anaesthetist has the option of using either clinical paralysing doses of non-depolarising muscle relaxants, or using small non-paralysing doses of nondepolarising muscle relaxants before succinylcholine to prevent muscle fasciculations. The disadvantages of the former are the slower onset of muscle relaxation and the longer duration of action, which may be excessive if relaxation was needed only for tracheal intubation or for very short procedures. The disadvantage of the latter is that the degree of muscle relaxation from succinylcholine may be reduced after pretreatment with a non-depolarising muscle relaxant.
In this study, pretreatment with fazadinium 0.075 mg. kg -~ effectively prevented succinylcholine-induced fasciculations and also significantly attenuated the increase in plasma potassium in all patients. Acidosis and alkalosis, which are known to alter plasma potassium levels, did not occur, as shown by the random blood gas determinations made during the sampling period in some of the patients. Barbiturates (e.g. thiopentone) are known to produce reduction in plasma potassium; 8'~2-~3 hence the choice of alfathesin as the induction agent in this study. Alfathesin does not cause any significant change in the plasma potassium levels, as shown in this study and that of Bali and Dundee, t2 so that the observed changes in potassium more truly reflect the effect of the muscle relaxants alone.
Konchigeri and Tay 8 gave pancuronium 20 I.tg. kg -t three minutes before the administration of succinylcholine 1 rag-kg -t to 25 patients and observed complete prevention of succinylcholine-induced serum potassium elevation. In fact, there was a consistent fall (though not statistically significant) in serum potassium concentration below control values. However, two of the 25 patients had muscle fasciculations.
Weintraub, et al. '4 gave 0. ling. kg -~ d-tubocurarine five minutes before succinylcholine and observed that the elevation of serum potassium produced was significantly reduced when compared with untreated controls. However, they also indicated that d-tubocurarine did not prevent the marked elevation of potassium in all patients. Bali and associates ~s observed that the attenuation of succinylcholine-induced hyperkalaemia was greater with pancuronium than with gallamine or d-tubocurarine. Dhanaraj, et al. 7 observed a significant increase in serum potassium after succinylcholine administration despite pretreatment with d-tubocurarine 3 mg. It may be, however, that this dose of d'tubocurarine was relatively too small. These reports indicate the different extent of attenuation produced by other non-depolarising muscle relaxants.
Succinylcholine acts at the motor end plate, decreasing the trans-membrane potential and increasing the ionic permeability of sodium and potassium in the process of depolarization. The rapid infux of sodium is followed by the efflux of intracellular potassium, resulting in a small increase in plasma potassium in subjects with normal muscle. ~6"~7 However, a twenty-fold increase in potassium efflux has been reported from denervated muscles. ~8 The mechanism by which non-depolarising muscle relaxants attenuate succinylcholine-induced hyperkalaemia is not well understood. However, it is postulated that they stabilize muscle cell membrane, decrease the number of depolarizations at the motor end-plate and facilitate intra-cellular influx of plasma potassium. ~s
In conclusion, fazadinium 0.075 mg-kg -1
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given about three minutes before the administration of suecinylcholine is effective in preventing muscle fasciculations and the associated increase in plasma potassium, in normal patients. Pretreatment with fazadinium may therefore be beneficial in patients at risk from succinylcholineinduced hyperkalaemia.
